PK5 fundamentals
BASILEA PHARMACEU financial statements, including revenue, expenses, profit, and loss
The total revenue of PK5 for the last semiannual is 76.29 M CHF, and it's 4.90% higher compared to the previous semiannual. The net income of H1 24 is 20.74 M CHF.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM